New early clinical study results support the potential of GN-K01, an investigational antibody being developed by GeNeuro, as a…
Articles by Patricia Inácio, PhD
The ALS Association is reminding amyotrophic lateral sclerosis (ALS) patients and caregivers that the open enrollment period for Medicare…
Note: This story was updated Oct. 19, 2021, to note that the trial is taking place at 90 clinical…
Amgen and Neumora Therapeutics announced that they are collaborating to develop precision therapies for amyotrophic lateral sclerosis…
Simultaneous injections of mesenchymal stem cells (MSCs) into the blood and spinal canal were found to delay disease progression…
Expansion Therapeutics has raised $80 million in funding to support the development of its small molecule RNA platform, called…
Research into gene therapies for motor neuron diseases (MNDs), a group of progressive neurological disorders that includes amyotrophic lateral sclerosis,…
The ALS Association has launched a new diagnostic guide — called thinkALS — to aid neurologists in more quickly…
A French national agency has cleared AB Science to resume patient enrollment in the Phase 3 clinical trial investigating…
ProMIS Neurosciences is advancing the development of antibodies against toxic TDP-43 protein clumps for the treatment of amyotrophic lateral…